Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Feb;39(2):993–999. doi: 10.1128/iai.39.2.993-999.1983

Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

S C Szu, S Clarke, J B Robbins
PMCID: PMC348048  PMID: 6832828

Abstract

Some anti-phosphocholine antibodies protect mice against challenge with certain, but not all, pneumococcal types. We found that both their isotype and reactivity with the cell wall C-polysaccharide of encapsulated pneumococci, as measured by immunodiffusion, were important in predicting the protective activity of anti-phosphocholine antibodies. We propose that the specificity of the protective antibodies includes the backbone of the phosphocholine-containing structure.

Full text

PDF

Images in this article

994Image
on p.994
995Image
on p.995

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Au C. C., Einsenstein T. K. Evaluation of the role of the pneumococcal Forssman antigen (F-polysaccharide) in the cross-serotype protection induced by pneumococcal subcellular preparations. Infect Immun. 1981 Jan;31(1):169–173. doi: 10.1128/iai.31.1.169-173.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Au C. C., Eisenstein T. K. Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae. Infect Immun. 1981 Jan;31(1):160–168. doi: 10.1128/iai.31.1.160-168.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Avery O. T., Morgan H. J. IMMUNOLOGICAL REACTIONS OF THE ISOLATED CARBOHYDRATE AND PROTEIN OF PNEUMOCOCCUS. J Exp Med. 1925 Aug 31;42(3):347–353. doi: 10.1084/jem.42.3.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bennett L. G., Glaudemans C. P. Binding studies with antibodies having phosphorylcholine specificity and fragments derived from their homologous Streptococcus pneumoniae type 27 capsular polysaccharide. J Immunol. 1979 Jun;122(6):2356–2362. [PubMed] [Google Scholar]
  5. Briles D. E., Claflin J. L., Schroer K., Forman C. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature. 1981 Nov 5;294(5836):88–90. doi: 10.1038/294088a0. [DOI] [PubMed] [Google Scholar]
  6. Briles D. E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med. 1981 Mar 1;153(3):694–705. doi: 10.1084/jem.153.3.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brundish D. E., Baddiley J. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem J. 1968 Dec;110(3):573–582. doi: 10.1042/bj1100573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dubos R. J. IMMUNIZATION OF EXPERIMENTAL ANIMALS WITH A SOLUBLE ANTIGEN EXTRACTED FROM PNEUMOCOCCI. J Exp Med. 1938 Apr 30;67(5):799–808. doi: 10.1084/jem.67.5.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frasch C. E., Parkes L., McNelis R. M., Gotschlich E. C. Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model. J Exp Med. 1976 Aug 1;144(2):319–329. doi: 10.1084/jem.144.2.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fujiwara M. Immunological properties of anti-pneumococcus rabbit serum as heterophile antibodies. Jpn J Exp Med. 1968 Feb;38(1):1–10. [PubMed] [Google Scholar]
  11. Gearhart P. J., Johnson N. D., Douglas R., Hood L. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts. Nature. 1981 May 7;291(5810):29–34. doi: 10.1038/291029a0. [DOI] [PubMed] [Google Scholar]
  12. Glaudemans C. P. The interaction of homogeneous, murine myeloma immunoglobulins with polysaccharide antigens. Adv Carbohydr Chem Biochem. 1975;31:313–346. doi: 10.1016/s0065-2318(08)60299-1. [DOI] [PubMed] [Google Scholar]
  13. Goebel W. F., Adams M. H. THE IMMUNOLOGICAL PROPERTIES OF THE HETEROPHILE ANTIGEN AND SOMATIC POLYSACCHARIDE OF PNEUMOCOCCUS. J Exp Med. 1943 May 1;77(5):435–449. doi: 10.1084/jem.77.5.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goodner K., Horsfall F. L. THE PROTECTIVE ACTION OF TYPE I ANTIPNEUMOCOCCUS SERUM IN MICE : I. THE QUANTITATIVE ASPECTS OF THE MOUSE PROTECTION TEST. J Exp Med. 1935 Aug 31;62(3):359–374. doi: 10.1084/jem.62.3.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gotschlich E. C., Liu T. Y. Structural and immunological studies on the pneumococcal C polysaccharide. J Biol Chem. 1967 Feb 10;242(3):463–470. [PubMed] [Google Scholar]
  16. Heidelberger M., Sia R. H., Kendall F. E. SPECIFIC PRECIPITATION AND MOUSE PROTECTION IN TYPE I ANTIPNEUMOCOCCUS SERA. J Exp Med. 1930 Sep 30;52(4):477–483. doi: 10.1084/jem.52.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jennings H. J., Lugowski C., Young N. M. Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1. Biochemistry. 1980 Sep 30;19(20):4712–4719. doi: 10.1021/bi00561a026. [DOI] [PubMed] [Google Scholar]
  18. Johnston R. B., Jr, Klemperer M. R., Alper C. A., Rosen F. S. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med. 1969 Jun 1;129(6):1275–1290. doi: 10.1084/jem.129.6.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leon M. A., Young N. M. Specificity for phosphorylcholine of six murine myeloma proteins reactive with Pneumococcus C polysaccharide and beta-lipoprotein. Biochemistry. 1971 Apr 13;10(8):1424–1429. doi: 10.1021/bi00784a024. [DOI] [PubMed] [Google Scholar]
  20. Macleod C. M., Hodges R. G., Heidelberger M., Bernhard W. G. PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES. J Exp Med. 1945 Nov 30;82(6):445–465. [PMC free article] [PubMed] [Google Scholar]
  21. Mold C., Nakayama S., Holzer T. J., Gewurz H., Du Clos T. W. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med. 1981 Nov 1;154(5):1703–1708. doi: 10.1084/jem.154.5.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oliveira E. B., Gotschlich E. C., Liu T. Y. Comparative studies on the binding properties of human and rabbit C-reactive proteins. J Immunol. 1980 Mar;124(3):1396–1402. [PubMed] [Google Scholar]
  23. Potter M. Antigen-binding myeloma proteins of mice. Adv Immunol. 1977;25:141–211. [PubMed] [Google Scholar]
  24. Poxton I. R., Tarelli E., Baddiley J. The structure of C-polysaccharide from the walls of Streptococcus pneumoniae. Biochem J. 1978 Dec 1;175(3):1033–1042. doi: 10.1042/bj1751033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schiffman G., Bornstein D. L., Austrian R. Capsulation of pneumococcus with soluble cell wall-like polysaccharide. II. Nonidentity of cell wall and soluble cell wall-like polysaccharides derived from the same and from different pneumococcal strains. J Exp Med. 1971 Sep 1;134(3 Pt 1):600–617. doi: 10.1084/jem.134.3.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schneerson R., Barrera O., Sutton A., Robbins J. B. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med. 1980 Aug 1;152(2):361–376. doi: 10.1084/jem.152.2.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tillett W. S. ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI. J Exp Med. 1928 Nov 30;48(6):791–804. doi: 10.1084/jem.48.6.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tillett W. S. STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS. J Exp Med. 1927 Jul 31;46(2):343–356. doi: 10.1084/jem.46.2.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Williams K. R., Claflin J. L. Clonotypes of anti-phosphocholine antibodies induced with Proteus morganii (Potter). II. Heterogeneity, class, and idiotypic analyses of the repertoires in BALB/c and A/HeJ mice. J Immunol. 1982 Feb;128(2):600–607. [PubMed] [Google Scholar]
  30. Winkelstein J. A., Tomasz A. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol. 1978 Jan;120(1):174–178. [PubMed] [Google Scholar]
  31. Wu T. T., Kabat E. A. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med. 1970 Aug 1;132(2):211–250. doi: 10.1084/jem.132.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Yother J., Forman C., Gray B. M., Briles D. E. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody. Infect Immun. 1982 Apr;36(1):184–188. doi: 10.1128/iai.36.1.184-188.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES